Non-compliance with growth hormone treatment in children is common and impairs linear growth.
about
Growth Hormone Research Society perspective on the development of long-acting growth hormone preparationsA long-acting human growth hormone with delayed clearance (VRS-317): results of a double-blind, placebo-controlled, single ascending dose study in growth hormone-deficient adultsImplications of a data-driven approach to treatment with growth hormone in children with growth hormone deficiency and Turner syndromeMore Favorable Metabolic Impact of Three-Times-Weekly versus Daily Growth Hormone Treatment in Naïve GH-Deficient ChildrenGrowth hormone (GH) dose-dependent IGF-I response relates to pubertal height gain.The variability of responses to growth hormone therapy in children with short statureValidation and ease of use of a new pen device for self-administration of recombinant human growth hormone: results from a two-center usability study.Adherence in children with growth hormone deficiency treated with r-hGH and the easypod™ deviceStories of experiences of care for growth hormone deficiency: the CRESCERE project.A Critical Appraisal of Growth Hormone Therapy in Growth Hormone Deficiency and Turner Syndrome Patients in Turkey.MOD-4023, a long-acting carboxy-terminal peptide-modified human growth hormone: results of a Phase 2 study in growth hormone-deficient adults.Growth Hormone Utilization Review in a Pediatric Primary Care Setting.Identification and management of poor response to growth-promoting therapy in children with short stature.Comparison of injection dose force, accuracy and precision among three growth hormone injection devices.Developing long-acting growth hormone formulations.Growth hormone delivery devices: current features and potential for enhanced treatment adherence.Parents' views on growth hormone treatment for their children: psychosocial issuesThe rationale and design of TransCon Growth Hormone for the treatment of growth hormone deficiency.Intranasal Human Growth Hormone (hGH) Induces IGF-1 Levels Comparable With Subcutaneous Injection With Lower Systemic Exposure to hGH in Healthy Volunteers.Comparison of intuitiveness, ease of use and preference among three prefilled, disposable growth hormone injection pens.Optimizing Patient Management and Adherence for Children Receiving Growth Hormone.Comparison of weight- vs body surface area-based growth hormone dosing for children: implications for response.Somapacitan, a once-weekly reversible albumin-binding GH derivative, in children with GH deficiency: A randomized dose-escalation trial.An analysis of product wastage arising from dosing increment granularity in four modern growth hormone administration devices.Parent preference in Switzerland for easy-to-use attributes of growth hormone injection devices quantified by willingness to pay.Long-acting growth hormone.Design of the long-term observational cohort study with recombinant human growth hormone in Korean children: LG Growth Study.Categorizing factors of adherence to parenteral treatment in growth hormone deficiencies and hemophilia: What should be the targets for future research?Improvement of treatment adherence with growth hormone by easypod™ device: experience of an Italian centre
P2860
Q30277101-BB9F0941-E014-4617-A9B4-FD75CA6EC3D7Q30540160-9E3FBC38-321B-4BA7-935A-14A08F76DEAEQ30621592-58759385-5CFC-422F-AE29-5B3808F65598Q33786906-A178BE02-AE24-45AE-AE0B-67C2C8594B85Q35872930-D618993D-5DD0-4B5A-88BC-255658CC4815Q36701011-2E7FF89A-B9DA-4F67-A274-782B249D0C10Q37165184-14290C73-4601-4834-8AF3-003D712E742FQ37410729-F0C59008-DEE3-4899-AAD8-DC39F0EB2701Q37474315-5C030A2B-7FFD-440C-8525-66F69D06F3C9Q37542296-B66C4CB2-5CF2-4A98-80A6-7E07E17947C5Q37626107-CC1CCB7D-F171-4BF2-B3F7-825C600C23FEQ37697929-0E31B957-602E-4472-9276-D04590F9D1B5Q38006057-F47B9834-FFFE-47E8-A231-222A60C6A797Q38096485-A503C746-2A47-4E83-92A7-C55CCF93CA11Q38105615-ED588736-5DF8-4884-872A-1E6083AAC2C1Q38975711-C2B42B9E-936A-4AD1-B57F-7CF38A04C853Q42281756-93EDDCCE-9A88-4669-A951-F4E1A8A26769Q42635183-86015104-646E-43D7-B3CC-DA46F755915BQ43103872-DF766763-4324-4DC9-9577-DF601CC36928Q45285454-899FAB1D-122B-42F6-BED2-E2570F552279Q47121420-69D51642-3525-44BC-9C48-3EA22426D6B8Q47215164-EA690370-BB4D-4D98-8AD9-6EAF7BB43B85Q48213660-51668B5C-4B9B-4DB7-8D92-4B76672B55A9Q53331706-2420DBC1-9ACF-45B4-BF39-3C16B6B6CA22Q53659540-4A9AA38C-E1C5-4567-BE29-9B14C12F07D7Q54576249-83C308CD-FCA0-4384-92AA-E79ACCF22B98Q55387453-75AFCD72-0FBB-4249-954A-15CEC007949BQ57817716-CC92A977-1995-4252-909B-D405CCF4658DQ59128572-00438F97-B96B-46C1-A451-323F087B7F33
P2860
Non-compliance with growth hormone treatment in children is common and impairs linear growth.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Non-compliance with growth hor ...... mon and impairs linear growth.
@ast
Non-compliance with growth hor ...... mon and impairs linear growth.
@en
type
label
Non-compliance with growth hor ...... mon and impairs linear growth.
@ast
Non-compliance with growth hor ...... mon and impairs linear growth.
@en
prefLabel
Non-compliance with growth hor ...... mon and impairs linear growth.
@ast
Non-compliance with growth hor ...... mon and impairs linear growth.
@en
P2093
P2860
P1433
P1476
Non-compliance with growth hor ...... mon and impairs linear growth.
@en
P2093
Elizabeth Robinson
José G B Derraik
Paul L Hofman
Theresa Delany
Wayne S Cutfield
P2860
P304
P356
10.1371/JOURNAL.PONE.0016223
P407
P577
2011-01-31T00:00:00Z